EXO|E From USA To UK: Croma-Pharma Partnership


Aesthetic Management Partners announced a partnership with Croma-Pharma to distribute EXO|E™ Skin Revitalizing Complex to European markets. The collaboration brings plant-based exosome technology to the EU and Switzerland.
Product Overview
The EXO|E™ product line consists of plant-derived secretory factors including exosomes, liposomes, growth factors, and anti-stressing compounds that support skin balance.
Three-Step Regimen
D|TOX™, EXO|E™, and RE|PAIR™ applies over 15 days for pre- and post-procedure use.
Executive Perspectives
CEO Erik Dowell stated the partnership "represents a significant stride in advancing innovation" within aesthetic medicine. Croma-Pharma CEO Andreas Prinz emphasized the opportunity to deliver "a revolutionary product line" to their customer base.
Applications
The water-based, natural, vegan skincare collection prepares skin for microneedling, RF treatments, and resurfacing procedures while serving as post-treatment recovery support.


